Upgrade to SI Premium - Free Trial

Rapid Micro Biosystems (RPID) Reiterated at Buy by Stifel: Top-Line Results as Expected

August 10, 2026 7:55 AM
Stifel analyst Daniel Arias reiterated a Buy rating and $8.00 price target on Rapid Micro Biosystems Inc (NASDAQ: RPID).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments